Advancements in Neurodegenerative Disease Research
This track focuses on the latest findings in the pathophysiology of neurodegenerative diseases. Researchers are invited to present novel insights that may lead to innovative therapeutic strategies.
Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.
Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.
Participant arrival, credential verification and virtual lobby access.
Informal networking for on-site and virtual participants.
Opening of the conference and introduction to its research focus.
This track focuses on the latest findings in the pathophysiology of neurodegenerative diseases. Researchers are invited to present novel insights that may lead to innovative therapeutic strategies.
This session will explore the design, implementation, and outcomes of clinical trials aimed at evaluating neurotherapeutic interventions. Emphasis will be placed on methodologies that enhance the efficacy of disease-modifying treatments.
This track will examine neuroprotective approaches tailored for aging individuals at risk of neurodegeneration. Discussions will include pharmacological and lifestyle interventions that promote brain health.
Refreshment interval and networking opportunity.
This session will delve into the mechanisms of neuroplasticity and its potential to facilitate recovery from brain injuries and disorders. Presentations will highlight therapeutic interventions that harness neuroplasticity for improved outcomes.
This track will showcase cutting-edge research on neurorepair strategies aimed at restoring function in damaged neural circuits. Contributions will include both experimental and clinical perspectives on neuroregeneration.
This session will focus on the translation of basic neuroscience research into clinical applications. Researchers are encouraged to share their experiences in overcoming barriers to effective therapeutic development.
Closing interaction and key takeaways from the first day.
On-site attendance confirmation and virtual lobby access.
Expert address on the future of the conference research domain.
This track will highlight the identification and validation of biomarkers for neurodegenerative diseases. The goal is to improve early diagnosis and monitor disease progression and treatment response.
This session will explore the intersection of neuroscience and mental health, focusing on how neurodegenerative processes may influence psychiatric conditions. Contributions will discuss potential therapeutic avenues for these comorbidities.
This track will cover the entire spectrum of neurotherapeutics, from drug discovery to clinical application. Participants will discuss challenges and successes in bringing new therapies to market.
Refreshment interval and professional networking.
This session will examine integrative health strategies that combine traditional and complementary therapies for brain health. The focus will be on holistic approaches that address the multifaceted nature of neurodegeneration.
This track will provide a platform for discussing emerging trends and future directions in neuroscience research. Participants are invited to share visionary ideas that could shape the landscape of neurodegenerative therapies.
Publication guidance and recognition of outstanding research contributions.
Conference summary, acknowledgements and formal conclusion.
Submit your research or complete your conference registration.